AstraZeneca’s Covid Drug Evusheld no longer authorised for use in the US; here's why2 min read . Updated: 27 Jan 2023, 02:07 PM IST
- Evusheld, was authorised in December 2021 to prevent Covid infection in high-risk people, but has been rendered less effective by the virus’ mutations.
The US health regulator has withdrawn emergency-use authorisation for AstraZeneca's COVID-19 antibody cocktail Evusheld as it’s unlikely to work against strains of the virus that are now dominant across the country.
Select your Category